National Health Investors, Inc. (NYSE:NHI – Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,479,704 shares, an increase of 19.1% from the February 26th total of 1,242,209 shares. Based on an average trading volume of 314,800 shares, the short-interest ratio is currently 4.7 days. Approximately 3.3% of the company’s shares are short sold.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of National Health Investors during the 4th quarter worth $55,301,000. M Holdings Securities Inc. purchased a new position in shares of National Health Investors in the 2nd quarter valued at about $36,607,000. JPMorgan Chase & Co. lifted its stake in shares of National Health Investors by 34.0% in the third quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares during the period. Freestone Grove Partners LP acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $21,869,000. Finally, Adage Capital Partners GP L.L.C. purchased a new stake in National Health Investors during the fourth quarter worth about $19,856,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on NHI shares. Wells Fargo & Company boosted their price objective on National Health Investors from $85.00 to $86.00 and gave the company an “equal weight” rating in a report on Friday, March 27th. Truist Financial raised their target price on National Health Investors from $85.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Cantor Fitzgerald set a $85.00 price target on shares of National Health Investors in a research note on Monday, January 5th. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research report on Friday, March 27th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a research note on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $86.83.
National Health Investors Trading Up 1.1%
Shares of National Health Investors stock opened at $81.73 on Thursday. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76. The company has a fifty day simple moving average of $84.62 and a 200-day simple moving average of $79.86. The stock has a market cap of $3.96 billion, a price-to-earnings ratio of 27.06, a PEG ratio of 4.38 and a beta of 0.65. National Health Investors has a 12-month low of $66.41 and a 12-month high of $91.38.
National Health Investors (NYSE:NHI – Get Free Report) last posted its earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.01). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The firm had revenue of $105.82 million during the quarter, compared to analysts’ expectations of $95.12 million. During the same period in the previous year, the firm posted $1.24 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities analysts forecast that National Health Investors will post 4.41 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s dividend payout ratio is currently 121.85%.
About National Health Investors
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Stories
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
